Closing Remarks

SPEAKER | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition

Introducing a Clinical Adoption Roadmap for Precision Cancer Care

Daryl Pritchard, who serves as the Senior Vice President for Science Policy at the Personalized Medicine Coalition, introduces the Coalition’s new Roadmap for Addressing Clinical Practice Gaps in Precision Cancer Care. SPEAKER | Daryl Pritchard, Ph.D., Senior Vice President, Science Policy, Personalized Medicine Coalition

Personalized Medicine: 20 Years Later

After the first sequencing of a human genome in 2003, officials from the U.S. National Institutes of Health introduced personalized medicine as a “newly created discipline” that promised to “make a profound difference to the health and well-being of all the people of this world.” Pioneering leaders reflect on the past, present, and future of […]

Clinical Adoption of Personalized Medicine: Opportunities and Challenges

For clinical care providers, personalized medicine may present opportunities to improve care for their patients and make better use of scarce resources by targeting treatments to those most likely to benefit from them. But spearheading the clinical adoption of personalized medicine is anything but easy. Representatives from leading clinical institutions reflect on opportunities and challenges. […]

Precision Partnership: Point32Health/GRAIL Discuss Payer Coverage Pilot Program for Multi-Cancer Early Detection Testing

GRAIL and Point32Health are evaluating the impact of blood-based screening tests used to detect cancers before they cause symptoms in a real-world health plan setting. Partner executives reflect on the findings to date. MODERATOR | Felice Freyer, President, Association of Health Care Journalists Joshua Ofman, M.D., President, GRAIL Kate Wallis, Vice President, Clinical Innovation, Point32Health

PhRMA’s Perspective on United States Public Policies and the Future of Personalized Medicine

As the Chief Medical Officer of the pharmaceutical industry’s leading trade association, Michael Ybarra, an emergency medicine physician, is helping industry executives shape and navigate shifting scientific, economic, and political landscapes in Washington and around the world. Dr. Ybarra shares the pharmaceutical industry’s point-of-view on the status and future of personalized medicine in light of […]

Opening Remarks

SPEAKER | Lincoln Nadauld, M.D., Ph.D., President, CEO, Culmination Bio